FFCP PHASE1:Mm9::chr13:96455780..96455820,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=6|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr13:96455780..96455820,-|id=chr13:96455780..96455820,-|ontology_enrichment_celltype=CL:0000838!4.51e-14!12;CL:0000542!6.34e-13!13;CL:0000051!6.34e-13!13;CL:0000084!1.47e-11!11;CL:0000827!1.47e-11!11;CL:0000738!1.11e-09!17;CL:0002087!1.11e-09!17;CL:0002031!3.69e-08!25;CL:0000988!8.76e-08!32;CL:0002032!8.76e-08!32;CL:0000037!8.76e-08!32;CL:0000566!8.76e-08!32;CL:0000837!8.76e-08!32;CL:0000624!1.82e-07!8|ontology_enrichment_celltype_v019_2=CL:0000815,1.03e-09,1;CL:0000792,1.03e-09,1;CL:0000355,1.79e-09,9;CL:0000084,1.27e-07,11;CL:0000827,1.27e-07,11;CL:0000838,4.93e-07,12|ontology_enrichment_disease=DOID:0060100!2.49e-12!3;DOID:4045!2.49e-12!3|ontology_enrichment_disease_v019_2=DOID:0060100,4.66e-27,3;DOID:4045,4.66e-27,3;DOID:0050686,6.75e-14,6|ontology_enrichment_uberon=|ontology_enrichment_uberon_v019_2=UBERON:0001134,1.79e-09,9;UBERON:0002036,1.79e-09,9;UBERON:0002385,1.79e-09,9;UBERON:0000486,1.79e-09,9;UBERON:0007503,1.79e-09,9;UBERON:0001015,1.79e-09,9;UBERON:0002329,1.79e-09,9;UBERON:0003082,1.79e-09,9;UBERON:0003059,1.79e-09,9;UBERON:0007282,1.79e-09,9;UBERON:0004290,1.79e-09,9;UBERON:0009618,1.79e-09,9;UBERON:0000383,1.39e-08,10;UBERON:0007524,7.44e-08,11;UBERON:0003077,7.44e-08,11;UBERON:0007285,7.44e-08,11|phase1_expression=0,0,0,0,0,0,0,1.03298658753261,0,0.468129052643987,0,0,0.171200729931206,1.57356724354195,0,0.202475267389826,0,0,0,0,0,0.496454756004426,1.82839852397255,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.11503772252743,5.4693474116666,7.85285615960697,42.940898626264,12.294818729252,11.1667381197165,0,0,0,0,0,0,0,0,0,0.167782606057736,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.161766849947409,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.189106080167819,0,0,0,0,0,0,0.702213187313235,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.164698954724011,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.156998727841375,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.32745138339963,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.139951452323658,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.117357238645754,0,0,0,0,0.316011120628178,0.202725215290164,0,0,0,0,0,0,0,0,0,0,0.0962118416403295,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr13:96455780..96455820,-}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=6 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr13:96455780..96455820,- | |||
|description=CAGE_peak_at_chr13:96455780..96455820,- | |||
|id=chr13:96455780..96455820,- | |||
|ontology_enrichment_celltype=CL:0000838!4.51e-14!12;CL:0000542!6.34e-13!13;CL:0000051!6.34e-13!13;CL:0000084!1.47e-11!11;CL:0000827!1.47e-11!11;CL:0000738!1.11e-09!17;CL:0002087!1.11e-09!17;CL:0002031!3.69e-08!25;CL:0000988!8.76e-08!32;CL:0002032!8.76e-08!32;CL:0000037!8.76e-08!32;CL:0000566!8.76e-08!32;CL:0000837!8.76e-08!32;CL:0000624!1.82e-07!8 | |||
|ontology_enrichment_celltype_v019_2=CL:0000815,1.03e-09,1;CL:0000792,1.03e-09,1;CL:0000355,1.79e-09,9;CL:0000084,1.27e-07,11;CL:0000827,1.27e-07,11;CL:0000838,4.93e-07,12 | |||
|ontology_enrichment_disease=DOID:0060100!2.49e-12!3;DOID:4045!2.49e-12!3 | |||
|ontology_enrichment_disease_v019_2=DOID:0060100,4.66e-27,3;DOID:4045,4.66e-27,3;DOID:0050686,6.75e-14,6 | |||
|ontology_enrichment_uberon= | |||
|ontology_enrichment_uberon_v019_2=UBERON:0001134,1.79e-09,9;UBERON:0002036,1.79e-09,9;UBERON:0002385,1.79e-09,9;UBERON:0000486,1.79e-09,9;UBERON:0007503,1.79e-09,9;UBERON:0001015,1.79e-09,9;UBERON:0002329,1.79e-09,9;UBERON:0003082,1.79e-09,9;UBERON:0003059,1.79e-09,9;UBERON:0007282,1.79e-09,9;UBERON:0004290,1.79e-09,9;UBERON:0009618,1.79e-09,9;UBERON:0000383,1.39e-08,10;UBERON:0007524,7.44e-08,11;UBERON:0003077,7.44e-08,11;UBERON:0007285,7.44e-08,11 | |||
|phase1_expression=0,0,0,0,0,0,0,1.03298658753261,0,0.468129052643987,0,0,0.171200729931206,1.57356724354195,0,0.202475267389826,0,0,0,0,0,0.496454756004426,1.82839852397255,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.11503772252743,5.4693474116666,7.85285615960697,42.940898626264,12.294818729252,11.1667381197165,0,0,0,0,0,0,0,0,0,0.167782606057736,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.161766849947409,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.189106080167819,0,0,0,0,0,0,0.702213187313235,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.164698954724011,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.156998727841375,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.32745138339963,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.139951452323658,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.117357238645754,0,0,0,0,0.316011120628178,0.202725215290164,0,0,0,0,0,0,0,0,0,0,0.0962118416403295,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr13:96455780..96455820,- | |||
}} |
Latest revision as of 20:12, 3 August 2015
Short description: | p@chr13:96455780..96455820, - |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr13:96455780..96455820, - |
Coexpression cluster: | MCL_coexpression_mm9:6 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
regulatory T cell | 1.03e-09 | 1 |
CD4-positive, CD25-positive, alpha-beta regulatory T cell | 1.03e-09 | 1 |
multi-potent skeletal muscle stem cell | 1.79e-09 | 9 |
T cell | 1.27e-07 | 11 |
pro-T cell | 1.27e-07 | 11 |
lymphoid lineage restricted progenitor cell | 4.93e-07 | 12 |
Ontology term | p-value | n |
---|---|---|
skeletal muscle tissue | 1.79e-09 | 9 |
striated muscle tissue | 1.79e-09 | 9 |
muscle tissue | 1.79e-09 | 9 |
multilaminar epithelium | 1.79e-09 | 9 |
epithelial vesicle | 1.79e-09 | 9 |
musculature | 1.79e-09 | 9 |
somite | 1.79e-09 | 9 |
myotome | 1.79e-09 | 9 |
presomitic mesoderm | 1.79e-09 | 9 |
presumptive segmental plate | 1.79e-09 | 9 |
dermomyotome | 1.79e-09 | 9 |
trunk paraxial mesoderm | 1.79e-09 | 9 |
musculature of body | 1.39e-08 | 10 |
dense mesenchyme tissue | 7.44e-08 | 11 |
paraxial mesoderm | 7.44e-08 | 11 |
presumptive paraxial mesoderm | 7.44e-08 | 11 |
Ontology term | p-value | n |
---|---|---|
musculoskeletal system cancer | 4.66e-27 | 3 |
muscle cancer | 4.66e-27 | 3 |
organ system cancer | 6.75e-14 | 6 |